Pretarsal blepharospasm: Clinical and electromyographic characteristics.
Blinking
Botulinum toxin
Electromyographic recordings
Eyelid-opening impairment
Pretarsal blepharospasm
Journal
Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology
ISSN: 1872-8952
Titre abrégé: Clin Neurophysiol
Pays: Netherlands
ID NLM: 100883319
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
received:
07
08
2019
revised:
11
03
2020
accepted:
20
03
2020
pubmed:
14
4
2020
medline:
11
5
2021
entrez:
14
4
2020
Statut:
ppublish
Résumé
To describe the clinical and electromyographic characteristics of blepharospasm caused by selective involvement of the pars pretarsalis of the orbicularis oculi muscle. Clinical assessment and simultaneous electromyographic recordings from levator palpebrae superioris and pars orbitaria and pretarsalis of orbicularis oculi muscles were performed in patients with blepharospasm and primary failure to botulinum toxin injections. Patients with selective abnormal electromyographic activity of the pars pretarsalis of the orbicularis oculi muscle were identified and treated with selective pretarsal injections of botulinum toxin. We found 24 patients with pretarsal blepharospasm confirmed by the electromyographic assessment. All of them were functionally blind. Three clinical-electromyographic patterns were identified: (a) Impairment of eyelid opening; (b) Increased blinking; (c) Spasms of eye closure combined with varying degrees of excessive blinking and impairment of eye-opening. Pretarsal injections of botulinum toxin induced a significant improvement in all patients and 50 % regained normal or near-normal vision. The clinical improvement was sustained after repeated pretarsal injections. Pretarsal blepharospasm can be suspected on clinical grounds and it can be confirmed by electromyographic recordings. Recognition of this type of blepharospasm is important because of its excellent response to botulinum toxin injections applied into the pretarsal part of the orbicularis oculi muscle.
Identifiants
pubmed: 32280019
pii: S1388-2457(20)30105-X
doi: 10.1016/j.clinph.2020.03.016
pii:
doi:
Substances chimiques
Botulinum Toxins
EC 3.4.24.69
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1678-1685Commentaires et corrections
Type : CommentIn
Informations de copyright
Copyright © 2020 International Federation of Clinical Neurophysiology. Published by Elsevier B.V. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest F. Grandas received honoraria for lecturing from Allergan S.A. The other authors: none.